These three CXCR4 inhibitory peptides were proven to be effective in inhibiting CXCR4-dependent migration and binding, P-ERK1/2-induction, calcium efflux, and tumor growth of renal cancer cells (Portella et al., 2013). This evidence concerns the gene CXCR4 and neoplasm.